Background: Spinal cord pathology is a major determinant of irreversible disability in progressive multiple sclerosis. The demyelinated lesion is a cardinal feature. Given the well-characterized anatomy of the spinal cord, the study of lesion topography and its extent of inflammatory activity may provide important clues about disease pathogenesis.
Methods: We studied a large cohort of cervical, thoracic, and lumbar spinal cord tissue derived from 119 pathologically confirmed multiple sclerosis cases. Immunohistochemistry was used to detect demyelination (proteolipid protein) and classify its inflammatory activity (CD68). Prevalence and distribution of demyelination, staged by lesion activity, was determined and topographical maps created to identify patterns of pathology using mixed models and permutation-based cluster analysis.
Results: Spinal cord lesions were observed in 76.5% of cases. Cases were more likely to harbour lesions at the cervical level compared to the lumbar region. Inflammatory activity (active or mixed active/inactive) was observed in 87.9% of cases. The distribution of lesions throughout the spinal cord mirrored the vascular network, spared the subpial surface, and consistently affected the dorsal columns, lateral corticospinal tracts, and the central canal. However, when present, subpial demyelination only affected a limited circumference of the spinal cord (<15%). Inflammatory lesions were more common in the white matter compared to grey matter. The presence of spinal cord lesions related strongly with clinical disease milestones, including time from onset to wheelchair and disease duration.
Conclusions: We demonstrate that spinal cord demyelination is common and highly inflammatory, has a predilection for the cervical level, and relates to clinical measures of disability even at late disease stages. Lesions relatively spare the subpial surface and instead preferentially affect the posterior and lateral columns and central canal, which points to a primary role of the vasculature in lesion pathogenesis. These findings fundamentally challenge the notion that demyelinating pathology in end-stage progressive multiple sclerosis is not inflammatory and that spinal cord lesions exhibit an outside-in topographical gradient. Taken together, this study highlights the importance of early intervention to target ongoing inflammatory demyelination and nominates vascular dysfunction as an important potential target to study further.